Once the favourite of investors, due to asset-light structure, high cashflow generating capability, healthy return ratios and visibility of sustainable growth over medium to long term, diagnostic companies are now losing their charm with a sharp jump in competitive intensity led by new entrants backed by large conglomerates.conglomerates.